Overview of interventions to enhance primary-care provider management of patients with substance-use disorders

Drug and Alcohol Review

Volumn 28, Issue 5, 2009, Pages 567-574

  Anderson, Peter ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Alcohol; Education; Organisation of care; Primary care provider; Tobacco

Indexed keywords

ADDICTION; ARTICLE; EDUCATION; HEALTH CARE PERSONNEL; HUMAN; METHODOLOGY; PATIENT EDUCATION; PRIMARY HEALTH CARE;

HEALTH PERSONNEL; HUMANS; PATIENT EDUCATION AS TOPIC; PRIMARY HEALTH CARE; SUBSTANCE-RELATED DISORDERS;

EID: 77049085994     PISSN: 09595236     EISSN: 14653362     Source Type: Journal    
DOI: 10.1111/j.1465-3362.2009.00113.x     Document Type: Article

References (46)

1. Rehm J, Taylor B, Room R. Global burden of disease from alcohol, illicit drugs and tobacco. Drug Alcohol Rev 2006;25:503-14.
2. Rehm J, Mathers C, Patra J, Popova S, Thavorncharoensap M, Teerawattananon Y. Global burden of disease and injury and economic cost attributable to alcohol use and alcohol use disorders. Lancet 2009;373:2223-33.
3. Baumberg B. The global economic burden of alcohol: a review and some suggestions. Drug Alcohol Rev 2006;25: 537-52.
4. Djoussé L, Gaziano MJ. Alcohol consumption and heart failure: a systematic review. Curr Atheroscler Rep 2008;10: 117-20.
5. Ezzati M, Lopez AD. Smoking and oral tobacco use. In: Ezzati M, Lopez AD, Rodgers A, Murray CJL, eds. Comparative quantification of health risks: global and regional burden of disease due to selected major risk factors. Geneva: World Health Organization, 2004:883-957.
6. Rehm J, Room R, Monteiro M, et al. Alcohol use. In: Ezzati M, Lopez AD, Rodgers A, Murray CJL, eds. Comparative quantification of health risks. Global and regional burden of disease attributable to selected major risk factors, vol. 1. Geneva: World Health Organization, 2004: 959-1108.
7. Degenhardt L, Hall WD, Warner-Smith M, Lynskey M. Illicit drug use. In: Ezzati M, Lopez A, Murray C, eds. Comparative risk assessment, vol. I. Geneva:World Health Organization, 2004:1109-76.
8. World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. Geneva: World Health Organization, 1992.
9. Kaner EFS, Dickinson HO, Beyer F, et al. The effectiveness of brief alcohol interventions in primary care settings: a systematic review. Drug Alcohol Rev 2009;28:301-23.
10. Eisenberg MJ, Filion KB, Yavin D, et al. Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials. Can Med Assoc J 2008;179:135-44.
11. Shanahan MD, Doran CM, Digiusto E, et al. A costeffectiveness analysis of heroin detoxification methods in the Australian National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD). Addict Behav 2005; 31:371-87.
12. Doran CM, Shanahan M, Mattick RP, Ali R, White J, Bell J. Buprenorphine versus methadone maintenance: a cost-effectiveness analysis. Drug Alcohol Depend 2003; 71:295-302.
13. Anderson P, Laurant M, Kaner E, Grol R, Wensing M. Engaging general practitioners in the management of alcohol problems: results of a meta-analysis. J Stud Alcohol 2004;65:191-99.
14. Anderson P, Jané-LLopis E. How can we increase the involvement of primary health care in the treatment of tobacco dependence? A meta-analysis. Addiction 2004;99: 299-312.
15. Deehan A, Templeton L, Taylor C, et al. Low detection rates, negative attitudes and the failure to meet the 'Health of the Nation' alcohol targets: findings from a national survey of GPs in England and Wales. Drug Alcohol Rev 1998;17:249-58.
16. Roche AM. Increasing primary care providers' willingness to intervene in alcohol- and drug-related problems: a review. Subst Abus 1996;17:201-17.
17. Pawson R. Evidence based policy: a realist perspective. London: Sage, 2005.
18. National Institute for Health and Clinical Excellence. Methods for development of NICE public health guidance. London: National Institute for Health and Clinical Excellence, 2006.
19. Bero L, Eccles M, Grimshaw J, et al. Cochrane Effective Practice and Organisation of Care Group. About the cochrane collaboration (Cochrane Review Groups (CRGs)). 2009. Issue 2. Art. No.: EPOC.
20. Amato L, Davoli M, Ali R, et al. Cochrane Drugs and Alcohol Group. About The Cochrane Collaboration (Cochrane Review Groups (CRGs)). 2007. Issue 2. Art. No.: ADDICTN.
21. Lancaster T, Stead LF, Cahill K, West R, Aveyard PN, Hughes JR. Cochrane Tobacco Addiction Group. About The Cochrane Collaboration (Cochrane Review Groups (CRGs)). 2009. Issue 2. Art. No.:TOBACCO.
22. Anderson P, Kaner E,Wutzke S, et al. Attitudes and managing alcohol problems in general practice: an interaction analysis based on Findings from a WHO Collaborative Study. Alcohol Alcohol 2004;39:351-6.
23. Funk M, Wutzke S, Kaner E, et al. A multi country controlled trial of strategies to promote dissemination and implementation of brief alcohol intervention in primary health care: Findings of a WHO Collaborative Study. J Stud Alcohol 2005;66:379-88.
24. Harvey EL, Glenny A-M, Kirk SFL, Summerbell CD. Improving health professionals' management and the organisation of care for overweight and obese people. Cochrane Database Syst Rev 2001. Issue 2. Art. No.: CD000984. DOI: 10.1002/14651858.CD000984.
25. Forsetlund L, Bjørndal A, Rashidian A, et al. Continuing education meetings and workshops: effects on professional practice and health care outcomes. Cochrane Database Syst Rev 2009. Issue 2. Art. No.: CD003030. DOI: 10.1002/14651858.CD003030.pub2.
26. O'Brien MA, Rogers S, Jamtvedt G, et al. Educational outreach visits: effects on professional practice and health care outcomes. Cochrane Database Syst Rev 2007. Issue 4. Art. No.: CD000409. DOI: 10.1002/14651858. CD000409.pub2.
27. Zwar N, Richmond R, Davidson D, Hasan I. Postgraduate education for doctors in smoking cessation. Drug Alcohol Rev 2009;28:466-73.
28. Sarna L, Bailous S, Rice VH, Wewers ME. Promoting tobacco dependence treatment in nursing education. Drug Alcohol Rev 2009;28:507-16.
29. Williams D. Preparing pharmacy students and pharmacists to provide tobacco cessation counseling. Drug Alcohol Rev 2009;28:533-40.
30. Gordon J, Albert D, Crews K, Fried J. Tobacco education in dentistry and dental hygiene. Drug Alcohol Rev 2009;28:517-32.
31. Reeves S, Zwarenstein M, Goldman J, et al. Interprofessional education: effects on professional practice and health care outcomes. Cochrane Database Syst Rev 2008. Issue 1. Art. No.: CD002213. DOI: 10.1002/14651858. CD002213.pub2.
32. Jamtvedt G, Young JM, Kristoffersen DT, O'Brien MA, Oxman AD. Audit and feedback: effects on professional practice and health care outcomes. Cochrane Database Syst Rev 2006. Issue 2. Art. No.: CD000259. DOI: 10.1002/14651858.CD000259.pub2.
33. Doumit G, Gattellari M, Grimshaw J, O'Brien MA. Local opinion leaders: effects on professional practice and health care outcomes. Cochrane Database Syst Rev 2007. Issue 1. Art. No.: CD000125. DOI: 10.1002/14651858. CD000125.pub3.
34. Grilli R, Ramsay C, Minozzi S. Mass media interventions: effects on health services utilisation. Cochrane Database Syst Rev 2002. Issue 1. Art. No.: CD000389. DOI: 10.1002/14651858.CD000389.
35. Cheater F, Baker R, Gillies C, et al. Tailored interventions to overcome identified barriers to change: effects on professional practice and health care outcomes. Cochrane Database Syst Rev 2005. Issue 3. Art. No.: CD005470. DOI: 10.1002/14651858.CD005470.
36. Barros PP, Martinez-Giralt X. 'Preventive health care and payment systems to providers,' UFAE and IAE Working Papers 507.02, Unitat de Fonaments de l'Anàlisi Econòmica (UAB) and Institut d'Anàlisi Econòmica (CSIC). 2002.
37. Gosden T, Forland F, Kristiansen I, et al. Capitation, salary, fee-for-service and mixed systems of payment: effects on the behaviour of primary care physicians. Cochrane Database Syst Rev 2000. Issue 3. Art. No.: CD002215. DOI: 10.1002/14651858.CD002215.
38. Giuffrida A, Gosden T, Forland F, et al. Target payments in primary care: effects on professional practice and health care outcomes. Cochrane Database Syst Rev 1999. Issue 4. Art. No.: CD000531. DOI: 10.1002/14651858. CD000531.
39. Department of Health.QOF Guidance.Available at: http://www.dh.gov.uk/en/Policyandguidance/Organisationpolicy/Primarycare /Primarycarecontracting/QOF/DH_4125653 (accessed June 2009).
40. Corrao G, Bagnardi V, Zambon A, Vecchia CL. A metaanalysis of alcohol consumption and the risk of 15 diseases. Prev Med 2004;38:613-19.
41. Heather N. WHO Collaborative project on identification and management of alcohol-related problems in primary care. Report on Phase IV. Geneva:World Health Organization, 2006. Available at: http://www.who.int/substance_abuse/publications/identification_managemen t_alcoholproblems_phaseiv.pdf (accessed June 2009).
42. Bettcher D, DeLand K, Schlundt J, et al. International public health instruments. In: Detels R, Beaglehole R, Lansang MA, Gulliford M, eds. Oxford textbook of public health, 5th edn. Oxford: Oxford University Press, 2009.
43. Anderson P, Kaner E,Wutzke S, et al. Attitudes and management of alcohol problems in general practice: descriptive analysis based on findings of a WHO international Collaborative Survey. Alcohol Alcohol 2003;38:597-601.
44. Goel RJ, Nelson MA. Economics of smoking cessation. In: Global efforts to combat smoking. Aldershot: Ashgate Publishing Company, 2008:91-100.
45. Chisholm D, Doran C, Shibuya K, Rehm J. Comparative cost-effectiveness of policy instruments for reducing the global burden of alcohol, tobacco and illicit drug use. Drug Alcohol Rev 2006;25:553-66.
46. Anderson P, Chisholm D, Fuhr DC. Effectiveness and cost-effectiveness of policies and programmes to reduce the harm caused by alcohol. Lancet 2009;373:2234-46.